Researchers have discovered another purpose for the gut-brain axis; relaying information to the hippocampus to store information about our environment and location.
Sweet tasting foods don't only trigger the taste buds, they also switch on a neurological pathway that begins in the gut. In the intestines, signals of sugar ingestion travel to the brain, sparking an appetite for more sweet foods. However, this pathway only responds to sugars, not artificial sweeteners.
Even during early stages of the disease, gut bacteria in those with Parkinson's differs significantly from those without the disease, a new study reports.
Findings may explain why children born by C-sections are more prone to suffer from chronic immune system diseases that those born via vaginal birth, researchers report.
Early-life exposure to antibiotics could impact brain development in areas associated with emotional and cognitive function, a new study reports. Researchers found penicillin exposure in infant mice altered the microbiome and gene expression in key areas of the developing brain.
Using data collected from 62.2 million Parkinson's patients, researchers discover a relationship between appendectomies and an increased risk of developing the disease. According to the analysis, patients who had their appendix removed were more than three times as likely to develop Parkinson's than those who had not.
A new study reports FDA approved artificial sweeteners and some sports supplements are toxic to digestive gut bacteria. Researchers say the consumption of artificial sweeteners can adversely affect gut microbial activity, causing a wide range of health issues from cancers to type-2 diabetes.
Experimental fecal transplant may help to improve autism symptoms, a new study reports.
Arizona State University researchers claim microbiota transfer therapy reduces symptoms associated with autism and gastrointestinal problems for two years post-treatment. The study suggests MTT may be a promising option for helping to treat children with ASD who also have GI problems. The researchers stress further research, including double-blind, placebo-controlled randomized trials with a larger cohort be carried out.